STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] PACS Group, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. officer reports sale of common stock

A PACS Group, Inc. officer, serving as Chief Legal Officer and Secretary, reported selling 159,556 shares of PACS common stock on 11/24/2025. The transaction was coded "S," indicating an open-market or private sale. The weighted average sale price was $29.8853 per share, with individual trades executed between $29.54 and $30.125 per share. Following this sale, the officer beneficially owns 755,836 PACS common shares directly.

The filer notes a willingness to provide details on the number of shares sold at each individual price within the reported range upon request.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MITCHELL JOHN TODD

(Last) (First) (Middle)
C/O PACS GROUP, INC.
262 N. UNIVERSITY AVE.

(Street)
FARMINGTON UT 84025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer & Sec.
3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/24/2025 S 159,556 D $29.8853(1) 755,836 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $29.54 to $30.125 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ John Mitchell 11/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PACS Group, Inc. (PACS) disclose?

An officer of PACS Group, Inc. reported selling 159,556 shares of PACS common stock on 11/24/2025 in a transaction coded as a sale ("S").

At what price were the PACS shares sold in this Form 4 filing?

The shares were sold at a weighted average price of $29.8853 per share, with individual trades ranging from $29.54 to $30.125 per share.

How many PACS shares does the reporting person own after the sale?

After the reported sale, the officer beneficially owns 755,836 shares of PACS Group, Inc. common stock, held directly.

Who is the reporting person in this PACS Form 4?

The reporting person is an officer of PACS Group, Inc., serving as Chief Legal Officer & Secretary, who filed individually (not as part of a group).

Was this PACS insider transaction executed in multiple trades?

Yes. The filing states the price is a weighted average and that the shares were sold in multiple transactions at prices between $29.54 and $30.125 per share.

Can investors obtain more detail on the individual PACS trade prices?

Yes. The reporting person undertakes to provide full information on the number of shares sold at each separate price within the reported range upon request.
PACS Group

NYSE:PACS

PACS Rankings

PACS Latest News

PACS Latest SEC Filings

PACS Stock Data

5.04B
44.67M
72.29%
29.09%
1.67%
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
FARMINGTON